Skip to Main Content
The Virta Treatment
How It Works
What We Treat
Outcomes
Research
For Patients
For Organizations
Employers
Health Plans
Resources
Patient Log In
Join Now
Join Now
All
Science & Research
Practical Tips
Patient Voice
Economic Impact
Search
Economic Impact & Company News
Type 2 Diabetes Reversal Leader Virta Health Appoints Shane Henderson as Chief Technology Officer
Diabetes Reversal Leader Virta Health Earns Validation Institute’s Highest Ranking for Delivering Industry-Leading Prescription Drug Savings
Virta Health Reveals Triple-Digit Growth With Health Plans Amid Industry Shift Towards Diabetes Reversal
Diabetes Reversal Leader Virta Health Appoints New Executives to Leadership Team and Board of Directors
Virta Health’s Diabetes Reversal Treatment Drives Savings of More Than $10k Per Patient Over Two Years, New Analysis Shows
What’s the Next Big Breakthrough in Healthcare? Virta Convenes 20+ Industry Leaders to Explore Bold Solutions to Our Most Daunting Challenges
Diabetes Reversal Leader Virta Health Demonstrates Promising Results on Mitigating COVID-19 Severity for People with Type 2 Diabetes
Diabetes Reversal Leader Virta Health Appoints Public Policy Veteran Cybele Bjorklund to Lead Government Efforts
Mashantucket Pequot Tribal Nation’s Partnership with Virta Health Shows Unprecedented Progress In Reversing the Community’s Type 2 Diabetes Epidemic
Diabetes Reversal Leader Virta Health Raises $133M Series E to Take Type 2 Diabetes Reversal Mainstream
Virta Health’s Reversal Treatment Prevents Progression to Type 2 Diabetes in 97% of Prediabetes Patients, New Research Shows
Using Virta’s Reversal Treatment To Help The 88 Million Americans With Prediabetes
Diabetes Reversal Leader Virta Health Appoints Chief Financial Officer
Virta Health Raises $65 Million Series D to Scale Type 2 Diabetes Reversal Treatments
This Veteran’s Day, Virta Honors a Very Special Request from One Retiring US Navy Officer
Expanding chronic disease reversal beyond type 2 diabetes
Virta Health Adds Prediabetes Reversal, Obesity Treatment, and Provider-Led Diabetes Management to Clinical Services
Virta Health Launches Beyond Telemedicine Conference, Convening 40+ Industry Leaders to Discuss Today’s Most Pressing Issues in Telehealth
Virta Health Partners With St. Louis Area Business Health Coalition to Expand Access to Type 2 Diabetes Reversal Treatment
Why We're Hopeful for the Future of Diabetes Care: Looking Back at the Past 5 Years at Virta Health
Virta Health Receives EHIR Traction Award for Spring 2020
Why I am Joining Virta Health After 40 Years in Diabetes Care
Virta Health Appoints Dr. Robert Ratner, Former Chief Scientific and Medical Officer of the American Diabetes Association, as Chief Medical Officer
Virta Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
Validating the outcomes of the Virta Treatment
Virta Health Raises $93 Million to Combat the $400B Type 2 Diabetes Epidemic and Expand Diabetes Reversal to Millions
Virta is rebuilding diabetes care from the ground up—here's why it's better for patients and providers
Veterans Living with Type 2 Diabetes Achieve Rapid Health Improvements in Virta Health Partnership with VA
Why U.S. Veterans Have us Excited for the Future of Type 2 Diabetes Care
Virta Health Partners with Accolade to Expand Access to Type 2 Diabetes Reversal Treatment
Virta Health’s Type 2 Diabetes Reversal Treatment Now Available to Blue Shield of California Members
Virta Health Engages with Willis Towers Watson to Accelerate Adoption of Type 2 Diabetes Reversal Treatment
New Virta research: sustainable diabetes reversal results lasting 2 years
New Virta Health Results Show Sustained Type 2 Diabetes Reversal at Two Years and Continued Reduction of Insulin
Virta Health Partners with U.S. Department of Veterans Affairs to Help Veterans with Type 2 Diabetes
Reversing Type 2 Diabetes with Bariatric Surgery, Very Low Calorie Diets, and Carbohydrate Restriction: A Review of the Evidence
4 Reasons the Virta Treatment Achieves a 90% Patient Retention Rate at One Year
Digital Health Veteran Derek Newell and Organizational Behavior Expert Lucia Guillory Join Virta Health
New Virta Health Results Add Improved Sleep as Benefit of the Virta Treatment
Virta's impact on NAFLD, the $100B problem affecting 60% of people with T2D
Virta Health Trial Demonstrates Improvement in Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
Survey says: the standard of type 2 diabetes care falls short for both patients and providers
Virta Health Puts 100% of Fees at Risk with Announcement of New Pricing Structure
Putting Our Money Where Our Medicine is: Reversing Diabetes with 100% of Fees at Risk
Finding Hope During National Diabetes Awareness Month
How Machine Learning Enhances the Virta Treatment
Virta Health Continues Rapid Growth with New Executives, New Customers, and Industry Validation for the Virta Treatment
Reflecting on 3 Years of Reversing Type 2 Diabetes at Virta Health
How to evaluate clinical outcomes: Three questions employers should ask vendors
Future Virta Research with Amy McKenzie, PhD, Senior Research Scientist
Motivation and Behavior Change: Why Tracking Isn’t Always Effective For Diabetes Treatment
Reversing the Trend of Diabetes Pharmaceutical Spending with the Virta Treatment
Virta Health Aiming to Eradicate Type 2 Diabetes in Indiana with Announcement of New Commercial Partnerships
Virta's Quest to Eliminate Type 2 Diabetes in Indiana
Virta Health Changing Status Quo in Chronic Disease Care with Strong Cardiovascular Outcomes from Type 2 Diabetes Reversal Study
Improving Cardiovascular Disease Risk Factors with the Virta Treatment
Virta Health Raises $45 Million to Expand Treatment for Type 2 Diabetes Reversal
With $45 million of new capital, Virta is ready to accelerate its growth
Type 2 Diabetes Reversal at Scale—What is Behind the Virta Treatment?
The Economic Benefits of Type 2 Diabetes Reversal
One Year Clinical Trial Outcomes Provide Evidence for Changing the Way We Care for Patients with Type 2 Diabetes
With Sustained Type 2 Diabetes Reversal, Management is Becoming a Thing of the Past
Virta Health’s Treatment for Sustained Type 2 Diabetes Reversal Provides New Hope for Chronic Disease Patients
Why Continuous Remote Telemedicine is the Future of Medicine
The Twenty Minute VC—An Interview with Sami Inkinen
Machine Learning in Healthcare
How Much Money Could Your State Save with Diabetes Reversal?
Former CMS Head Dr. Don Berwick Joins Virta Health Board of Directors
National Spending on Privately Insured People with Diabetes Continues to Climb
From Initial Success to Sustainability in Diabetes Reversal—a Snapshot of Six Month Outcomes
Boilermakers, Difference Makers
Purdue, Virta Health Partner In New Approach To Treat Type 2 Diabetes
Death, Taxes, and Diabetes Progression? One of These is Not Like the Others.
Virta Health Launches to Reverse Type 2 Diabetes as New Study Demonstrates Reversal Possible Without Surgery
The Science of Diabetes Reversal—Virta Clinical Results
We are on a Mission to Reverse Type 2 Diabetes in 100 Million People
.jpg)
